VYNE Therapeutics Inc. (NASDAQ:VYNE) went down by -0.62% from its latest closing price compared to the recent 1-year high of $7.48. The company’s stock price has collected 5.92% of gains in the last five trading sessions. Press Release reported on 10/01/20 that VYNE Therapeutics Announces ZILXI(TM) (minocycline) topical foam, 1.5% Available in Pharmacies Nationwide on October 1st
Is It Worth Investing in VYNE Therapeutics Inc. (NASDAQ :VYNE) Right Now?
Opinions of the stock are interesting as 7 analysts out of 7 who provided ratings for VYNE Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The average price from analysts is $7.00. VYNE currently public float of 138.08M and currently shorts hold a 4.88% ratio of that float. Today, the average trading volume of VYNE was 2.28M shares.
VYNE’s Market Performance
VYNE stocks went up by 5.92% for the week, with a monthly jump of 13.38% and a quarterly performance of -2.42%, while its annual performance rate touched -63.07%. The volatility ratio for the week stands at 7.20% while the volatility levels for the past 30 days are set at 10.11% for VYNE Therapeutics Inc.. The simple moving average for the period of the last 20 days is 0.94% for VYNE stocks with a simple moving average of -40.84% for the last 200 days.
VYNE Trading at 0.75% from the 50-Day Moving Average
After a stumble in the market that brought VYNE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.48% of loss for the given period.
Volatility was left at 10.11%, however, over the last 30 days, the volatility rate increased by 7.20%, as shares surge +16.67% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -3.59% lower at present.
During the last 5 trading sessions, VYNE rose by +5.92%, which changed the moving average for the period of 200-days by -66.87% in comparison to the 20-day moving average, which settled at $1.6065. In addition, VYNE Therapeutics Inc. saw -65.30% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for VYNE
Equity return is now at value -400.60, with -209.80 for asset returns.